Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2012 | In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles | Hsieh W.-J.; Liang C.-J.; Chieh J.-J.; SHU-HUEI WANG ; I-RUE LAI ; JYH-HORNG CHEN ; FU-HSIUNG CHANG ; Tseng W.-K.; Yang S.-Y.; CHAU-CHUNG WU ; YUH-LIEN CHEN | International Journal of Nanomedicine | 62 | 52 | |
2011 | In-vitro diagnosis of colon cancer using bio-functionalized magnetic nanoparticles | Hong C.-Y.; Yang S.-Y.; KAI-WEN HUANG ; Horng H.-E.; Yang H.-C. | Proceedings of the ASME Design Engineering Technical Conference | 0 | 0 | |
2013 | Inducible deletion of the Blimp-1 gene in adult epidermis causes granulocyte-dominated chronic skin inflammation in mice | Chiang M.-F.; Yang S.-Y.; Lin I.-Y.; JIN-BON HONG ; SUNG-JAN LIN ; Ying H.-Y.; Chen C.-M.; Wu S.-Y.; Liu F.-T.; Lin K.-I. | Proceedings of the National Academy of Sciences of the United States of America | 29 | 29 | |
2013 | An interactive method for achieving ergonomically optimum conditions during laparoscopic surgery | Hu C.-L.; CHING-YAO YANG ; Lin Z.-S.; Yang S.-Y.; Kuo C.-H.; MING-TSAN LIN | Journal of Robotic Surgery | 1 | 0 | |
2021 | Investigation of the Number of Tests Required for Assaying Plasma Biomarkers Associated with Alzheimer’s Disease Using Immunomagnetic Reduction | Liu H.-C.; Chen H.-H.; Ho C.-S.; Chang J.-F.; Lin C.-C.; MING-JANG CHIU ; TA-FU CHEN ; Hu C.-J.; Yan S.-H.; Sun Y.; Yang S.-Y. | Neurology and Therapy | 0 | 0 | |
2001 | The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6 | Kuo M.-L.; Chuang S.-E.; MING-TSAN LIN ; Yang S.-Y. | Oncogene | 129 | 127 | |
2015 | Leisure activities, apolipoprotein E e4 status, and the risk of dementia | Yang S.-Y.; Weng P.-H.; JEN-HAU CHEN ; Chiou J.-M.; Lew-Ting C.-Y.; TA-FU CHEN ; Sun Y.; Wen L.-L.; Yip P.-K.; Chu Y.-M.; YEN-CHING CHEN | Journal of the Formosan Medical Association | 16 | 14 | |
2006 | Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area | WEI-LIANG SHIH ; MING-WHEI YU ; PEI-JER CHEN ; Shiou-Hwei Yeh ; Lo M.-T.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; CHUN-JEN LIU ; Lee S.-D.; Lin C.-L.; CHUHSING KATE HSIAO ; Yang S.-Y.; Chen C.-J. | Oncogene | 17 | 14 | |
2019 | Long-Term Storage Effects on Stability of Aβ1-40, Aβ1-42, and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays | MING-JANG CHIU ; Lue L.-F.; Sabbagh M.N.; TA-FU CHEN ; Chen H.H.; Yang S.-Y. | Dementia and Geriatric Cognitive Disorders Extra | 15 | 13 | |
2011 | Low-Field nuclear magnetic resonance and magnetic resonance imaging using a high-tc squid for tumor detection | KAI-WEN HUANG ; Liao S.-H.; Yang H.-C.; Chen H.-H.; Horng H.-E.; Chen M.J.; Yang S.-Y. | IEEE Transactions on Applied Superconductivity | 4 | 4 | |
2018 | Mass-size distribution and concentration of metals from personal exposure to arc welding fume in pipeline construction: A case report | Yang S.-Y.; Lin J.-M.; Young L.-H.; CHING-WEN CHANG | Industrial Health | 8 | 7 | |
2020 | Nanoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer's disease – A cross-validation study | MING-JANG CHIU ; TA-FU CHEN ; Hu C.-J.; Yan S.-H.; Sun Y.; Liu B.-H.; Chang Y.-T.; Yang C.-C.; Yang S.-Y. | Nanomedicine: Nanotechnology, Biology, and Medicine | 21 | 19 | |
1999 | A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers | MING-WHEI YU ; Yang S.-Y.; Chiu Y.-H.; Chiang Y.-C.; Liaw Y.-F.; Chen C.-J. | Hepatology | 136 | 120 | |
2014 | Patient- and clinic visit-related factors associated with potentially inappropriate medication use among older home healthcare service recipients | CHIRN-BIN CHANG ; Lai H.-Y.; Yang S.-Y.; Wu R.-S.; Liu H.-C.; Hsu H.-Y.; Hwang S.-J.; DING-CHENG CHAN | PLoS ONE | 35 | 28 | |
2018 | Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease | Teunissen C.E.; MING-JANG CHIU ; Yang C.-C.; Yang S.-Y.; Scheltens P.; Zetterberg H.; Blennow K. | Journal of Alzheimer's disease : JAD | 94 | 88 | |
2014 | Plasma Aβ but not tau is related to brain PiB retention in early Alzheimer's disease | KAI-YUAN TZEN ; Yang S.-Y.; TA-FU CHEN ; Cheng T.-W.; Horng H.-E.; Wen H.-P.; Huang Y.-Y.; Shiue C.-Y.; MING-JANG CHIU | ACS Chemical Neuroscience | 87 | 86 | |
2018 | Plasma biomarkers differentiate Parkinson's disease from atypical parkinsonism syndromes | CHIN-HSIEN LIN ; Yang S.-Y.; Horng H.-E.; Yang C.-C.; Chieh J.-J.; Chen H.-H.; Liu B.-H.; MING-JANG CHIU | Frontiers in Aging Neuroscience | 41 | 36 | |
2017 | Plasma levels of Aβ42 and Tau identified probable Alzheimer's dementia: Findings in two cohorts | Lue L.-F.; MING-JANG CHIU et al. ; Chiu M.-J.; Jing N.; Snyder N.L.; Schmitz C.; Guerra A.; Belden C.M.; TA-FU CHEN ; Yang C.-C.; Yang S.-Y.; Walker D.G.; Chen K.; Reiman E.M. | Frontiers in Aging Neuroscience | 80 | 75 | |
2019 | Plasma ps129-α-synuclein is a surrogate biofluid marker of motor severity and progression in parkinson's disease | CHIN-HSIEN LIN ; Liu H.-C.; Yang S.-Y.; KAI-CHIEN YANG ; CHAU-CHUNG WU ; MING-JANG CHIU | Journal of Clinical Medicine | 20 | 17 | |
2014 | Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease | MING-JANG CHIU ; YA-FANG CHEN ; TA-FU CHEN ; Yang S.-Y.; Yang F.-P.G.; Tseng T.-W.; Chieh J.-J.; Chen J.-C.R.; KAI-YUAN TZEN ; Hua M.-S.; Horng H.-E. | Human Brain Mapping | 115 | 106 |